ࡱ> % ['bjbj 7ziEdiEdh((mmmmm8d g !!(G!G!G!""""""fffffffjlTfm""""""""""fmmG!G!f$$$""mG!mG!f$""f$$[cG! "_:ff0g`m#mtccLmm!f|""""$""""""""""ff$""""""g""""""""m""""""""""""""""""( 3: PLACEBOS Definition Uses Characteristics History Effects Mechanisms of Action Placebo Sales Definition A medicine with no inherent pharmacological activity that is effective by virtue of the factor of suggestion attendant upon its administration. While many people think a "placebo" is simply a sugar pill or other medicine with no active ingredients, the term has a broader meaning. The "placebo effect" includes any improvements in a patient not specifically due to a particular ingredient in a treatment, like a drug or surgical procedure. Thus, procedures (seeing a Dr.) can have placebo effects. Uses Medical Dr. may lack effective treatment, may need to mark time while awaiting results of tests, or be harassed by the patient. Giving patient something may make them both feel good. By giving medication, Dr. is validating patients experience of a problem (it's not just nerves) which may produce a different attitude in family members, etc. Experimental In a single-blind study, they help eliminate effects due to subject expectations. In a double-blind study, they can help eliminate experimenter bias as well. Experimental Control Concepts Single Blind - Subject does not know what treatment condition they are in. Ex. They know they are in a study of drug effects, but do not know whether they are receiving the drug or placebo (blind). Double Blind In addition, to the subject, the person scoring the dependent measure (collecting the relevant data) is also blind. Major problem is that patients & physicians can often tell who is getting active medication & who is getting placebo, because only true medication has side effects. Active Placebo - Produces side effects similar to active drug but has no medical consequences. Ex. If a purported antipsychotic causes excess salivation, then the placebo should too. Characteristics Color Colorless are less effective. Some advise red, yellow, or brown rather than green or blue which are associated with poisonous/external use only liquids. Size Very large or very small are more effective than moderate sized. Small impress with potency & large with amount. Taste Bitter or highly flavored are more effective than tasteless. Route of Administration Injections are thought to be more effective than pills. Familiarity Unusual names are more effective. Other Comments Should be delivered at the cost of some discomfort to the patient. Works best when labeled a product of recent research. History The history of medical treatment up to about 100 years ago could be considered the history of the placebo effect. Most Common Placebos Why the Silence? Why the Recent Attention? Most Common Placebos Unicorns Horn Actually came from ivory of the elephant. Used to detect & protect against poisons in wines. Bezoar Stones Crystallized tears from a deer bitten by a snake. Actually came from gallstones of animals such as a goat. Used as a universal antidote. Theriac Main ingredient was flesh of vipers & had many others. Used as a universal antidote. Powdered Egyptian Mummy Came from who knows what. Used to heal wounds & as a universal remedy. Why the Silence? The PE goes against the philosophy of medicine. If patients can be cured through psychological variables, then why do we need medical science? Sugar pills are not profitable. Drug companies want to know whether their drugs work, so they can sell them. Why the Recent Attention? Increasing number of effective drugs. Repetitive nature of the outrageous new drug phenomena. Increased concern about methodological problems in research. Increased amount of research (more scientists than ever before). Effects Examples Similarity to Active Drugs Aphrodisiacs Examples Beecher (1955) Selected 15 studies at random dealing with the common cold, cough, post operative pain, etc. Found that in 1082 patients, (35% reported relief from a placebo. Haas et al. (1963) Keats & Beecher (1966) Showed objective effects. Found of subjects given a placebo (they thought was a narcotic) responded with constricted pupils. Roberts et al. (1993) Haas et al. (1963) - Part I Symptom# studies# patients% respondingHeadache9458862G.I. Disorders428458Seasickness13358Rheumatism835849Colds324645Coughing24441Neurosis613534Migraine5490832Pain2596128Dysmenorrhea48824Multiple Sclerosis315224Alcoholism521022Hay Fever14222Skin Diseases21921Psychosis1782819Parkinsonism23119Angina Pectoris1034618Hypertension924017Constipation314412Sleep Disturbance33407Asthma2195Epilepsy1720Roberts et al (1993) Re-examined data from initial clinical trials of 5 procedures/drugs which had at first seemed highly promising, and were later shown useless. The physicians, who offered the treatments as part of an early clinical trial & believed in their efficacy, told their patients the various approaches were new & promising. Because these were very early trials, no control groups were used. Of a total of 6,931 patients receiving treatment, 40% reported excellent, 30% good, & 30% poor results. The authors believe that for relatively mild medical problems, under the best conditions the placebo effect will produce positive results in roughly two-thirds of patients. However, the effects would not be nearly as strong for serious diseases such as AIDS or cancer. In the more severe disorders, the placebo effects would be mainly in terms of patient's subjective complaints, not their physical symptoms. The authors believe the improvements associated with placebos are caused by factors like patients unconsciously exaggerating improvements of their symptoms in order to please their doctors, and doctors who hope for positive results skewing their evaluations of symptoms favorably. Similarity to Active Drugs Placebos have been shown to have side effects that are dose dependent. They show time-effect relationships (although they generally take longer to the peak effect & have a shorter duration of effect). They may show tolerance. Aphrodisiacs In 1995, at least 4 men died after eating an aphrodisiac, which contained dried toad secretions and was supposed to be applied to the genitals. The product was sold in NYC under the names "Stone," "Love Stone," "Black Stone," and "Rock Hard," in containers without labels listing ingredients or directions for use, said the CDC. The best known aphrodisiac is Spanish fly (which is a blister beetle). It contains cantharidin, which is a powerful blister-inducing substance that irritates the body's genitourinary tract when applied topically but can result in poisoning if ingested. BTW, viagra increases blood flow rather than libido, so it is an ergogenic drug rather than a aphrodisiac. Drugs that are thought to interact primarily with receptors for DA can stimulate the sex drive, although in most cases this is an undesirable side effect. Exs. include antidepressant Welubutrin (bupropion) & anti-Parkinson's drug Eldepryl (selegiline). Drugs that act primarily on 5-HT receptors, most notably antidepressant Prozac (fluoxitine), appear to depress libido. Some data suggests Ginseng may improve ED. FDA plans to approve the drugAddyi ( HYPERLINK "http://news.health.com/2015/06/05/fda-panel-endorses-womens-libido-pill/" flibanserin)in 8/15, for the treatment of low libido in women. I am sure we will see more in this area. Mechanisms of Action I There are at least 4: Animism - Involves magical thinking. Suggestion - A trusted Dr. says it will work so it does. Endorphin System Activation Endorphins are neurotransmitters that closely resemble opiate drugs. Classical Conditioning If this is so, a placebo effect should observable in animals & it is. When animals are injected with an active drug, & then with saline, they show physiological/behavioral changes in the same direction as those produced by the active drug.     M. Plonsky, Ph.D. Psychoactive Drugs Notes - Placebos Page  PAGE 4 of  NUMPAGES 5  ]hi  * 4 _ d l D M , f ͻ͙uiZKh"h%56CJ]aJh"hZ56CJ]aJh%56CJ]aJ#h"hg5CJOJQJ^JaJ#h"hZ5CJOJQJ^JaJ&h"hZ5>*CJOJQJ^JaJhgh%PD56CJaJ#h%PDh%PD5CJOJQJ^JaJhcShZCJaJ hcShZCJ$OJQJ^JaJ ,hcShZ9B*CJ0OJQJ^JaJ0ph )19N]h# _ d l   g gd{ & Fgd" & F gdC & Fgd" & Fgd" & Fgd%PDgdcS$ & F1$7$8$H$^gdcS $^`a$f g L X u,-.<=CTYZ$ƴƴƴښچtt`N`Ntt#hghZ5CJOJQJ^JaJ&hghZ5>*CJOJQJ^JaJ#hChZ5CJOJQJ^JaJ&hChZ5>*CJOJQJ^JaJh{CJaJ#hgh 75CJOJQJ^JaJ#h 7h 75CJOJQJ^JaJ&h 7h 75>*CJOJQJ^JaJhcSh{CJaJh{h{CJaJhZ5CJOJQJ^JaJ L u-=T$g->Yn & FgdC ^`gdcS & FgdC & F gdC & F gdg & F gdC & F gdCgd{ & F gd 7XYn|t{2C%)C];Ct}{dR#h&)h&)5CJOJQJ^JaJ, jhX,hZ5CJOJQJ\^JaJhX,hZ56CJ]aJhghuC56CJ]aJ#huChuC5CJOJQJ^JaJ#hX,hZ5CJOJQJ^JaJ&hX,hZ5>*CJOJQJ^JaJ#hChZ5CJOJQJ^JaJ#hChZ5CJOJQJ^JaJhcShZCJaJnt2CC];CLgt}+> & FgdX, & FgdX, & FgdX, & FgdX, & FgdX, & FgduCgdcS & FgdX,>U%2$$If^`a$gdeV$If^`gdeVgdcS & FgdX, & FgdX, & FgdX,$'23FG_`tu*+=>TUijμμμΪ hgh"CJOJQJ^JaJ#hgh">*CJOJQJ^JaJ#hgh"5CJOJQJ^JaJ&hgh"5>*CJOJQJ^JaJhcShZCJaJ#h&)hZ5CJOJQJ^JaJ523<>CFWF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVTFGVX\_WF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVT_`lnqtWF222$$If^`a$gdeV$If^`gdeVkdZ$$IfTl\ 2( y t0644 lalyteVTtuWF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkda$$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkdh$$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVT WF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVT!#'*WF222$$If^`a$gdeV$If^`gdeVkdo$$IfTl\ 2( y t0644 lalyteVT*+57:=WF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVT=>LNQTWF222$$If^`a$gdeV$If^`gdeVkd$$IfTl\ 2( y t0644 lalyteVTTU_bfiWF222$$If^`a$gdeV$If^`gdeVkdv $$IfTl\ 2( y t0644 lalyteVTijwy|WF222$$If^`a$gdeV$If^`gdeVkd# $$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd $$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd} $$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd* $$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd $$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd $$IfTl\ 2( y t0644 lalyteVTWF222$$If^`a$gdeV$If^`gdeVkd1$$IfTl\ 2( y t0644 lalyteVTWRJJJJJJ & FgdG&gdG&kd$$IfTl\ 2( y t0644 lalyteVT~ ^!i!" " "ȺڨykykykykykyXG hghgOJQJ\x8$hghgOJQJ\^Jx8hz#{h 56CJaJ#h h 5CJOJQJ^JaJhcShZCJaJ#hX,hZ5CJOJQJ^JaJ#hX,hG&5CJOJQJ^JaJhz#{hG&56CJaJ#hG&hG&5CJOJQJ^JaJhcShG&CJaJhG&CJaJ#hgh"CJOJQJ\^JaJ !"s"q##$$$%(%M%%%& & Fgd" & Fgd" 0^`0! & F h3$5$9D^hgdg & Fgd gdcS & FgdX, & FgdG&gdG& """r"s"y"""##*#+#5#̿s`M<,hghg6\]x 8 hghgOJQJ\x8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8hghgOJQJ^J$hghgOJQJ\^Jx8 hghgOJQJ\x8hghg6\]x8 5#6#B#D#U#Y#Z#b#c#d#n#p#q#ɶq^K8+hghgOJQJ^J$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8 hghgOJQJ\x8hghg6\]x8 hghgOJQJ\x8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx 8$hghgOJQJ\^Jx 8$hghgOJQJ\^Jx 8 hghgOJQJ\x 8 q#|############Ǵ}mZG4!$hghgOJQJ\^Jx 8$hghgOJQJ\^Jx 8$hghgOJQJ\^Jx 8$hghgOJQJ\^Jx 8hghg6\]x 8 hghgOJQJ\x8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8 #####$$$ $0$1$6$7$8$Ǻn]M<)$hghgOJQJ\^Jx8 hghgOJQJ\x8hghg6\]x8 hghgOJQJ\x8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8hghgOJQJ^J$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8$hghgOJQJ\^Jx8 8$9$$$$$$$$$$$$$%詖p]P=P2hcShZCJaJ$hghgOJQJ\^Jx 8hghgOJQJ^J$hghgOJQJ\^Jx 8$hghgOJQJ\^Jx 8$hghgOJQJ\^Jx 8$hghgOJQJ\^Jx 8$hghgOJQJ\^Jx81hghg0J"B*OJQJ\^Jphx8$hghgOJQJ\^Jx8-jhghgOJQJU\^Jx8%(%/%2%M%W%X%Z%%%%%%&&&&&&&&&;'<'B'C'D'E'I'J'T'Ǹ٦힚vevOveve+hQG0J 5CJOJQJ\^JmHnHu heV0J 5CJOJQJ\^J)jheV0J 5CJOJQJU\^JheV5CJOJQJ\^JhjhU#h"h"5CJOJQJ^JaJhlL5CJOJQJ^JaJ#hlLhlL5CJOJQJ^JaJ&h"hZ5>*CJOJQJ^JaJ#h"hZ5CJOJQJ^JaJ&H&&&&&&&&&&X'Y'Z'[' dgdeV & Fgd"T'U'V'W'X'Y'Z'['ȶ#h"hZ5CJOJQJ^JaJhhg)NheV+hQG0J 5CJOJQJ\^JmHnHu)jheV0J 5CJOJQJU\^J50P/ =!"#$% Dp$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT$$Ifl!vh#v #v#v#vy:V l t065 555yalyteVT#w8888888666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@6666OJQJ_HmH nH sH tH J`J Normal dCJ_HaJmH sH tH r@r  Heading 1+d1$7$8$@&H$^`5CJ@OJQJ\^JaJ@r@r 0 Heading 2+>d1$7$8$@&H$^`>5CJ8OJQJ\^JaJ8r@r 0 Heading 3+d1$7$8$@&H$^`5CJ0OJQJ\^JaJ0rr 0 Heading 4+ d1$7$8$@&H$^ `5CJ0OJQJ\^JaJ0r@r  Heading 5+ d1$7$8$@&H$^ `5CJ0OJQJ\^JaJ0rr 0 Heading 6+xd1$7$8$@&H$^x`5CJ0OJQJ\^JaJ0rr 0 Heading 7+Hd1$7$8$@&H$^H`5CJ0OJQJ\^JaJ0rr 0 Heading 8+d1$7$8$@&H$^`5CJ0OJQJ\^JaJ0r r 0 Heading 9+ d1$7$8$@&H$^`5CJ0OJQJ\^JaJ0DA D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List V/V Heading 1 Char"5CJ KH OJPJQJ\^JaJ X/X Heading 2 Char$56CJOJPJQJ\]^JaJR/R Heading 3 Char5CJOJPJQJ\^JaJF/!F Heading 4 Char5CJ\^JaJL/1L Heading 5 Char56CJ\]^JaJ>/A> Heading 6 Char 5\^J@/Q@ Heading 7 Char CJ^JaJF/aF Heading 8 Char6CJ]^JaJD/qD  Heading 9 CharOJPJQJ^J~o~ cS slide title+$$ $dNa$"5CJOJQJ\_HmH sH tH xx " Table Grid7:V0 d^J4@4 eV0Header  H$2/2 eV0 Header Char^J4 4 eV0Footer  H$2/2 eV0 Footer Char^JRR eV0 Balloon Text dCJOJQJ^JaJN/N eV0Balloon Text CharCJOJQJ^JaJ2)`2 eV0 Page Number^J^@^ g List Paragraph!d^m$CJOJQJaJ4U`!4 g0 Hyperlink >*phPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VGRU1a$N% ʣꂣKЛjVkUDRKQj/dR*SxMPsʧJ5$4vq^WCʽ D{>̳`3REB=꽻Ut Qy@֐\.X7<:+& 0h @>nƭBVqu ѡ{5kP?O&Cנ Aw0kPo۵(h[5($=CVs]mY2zw`nKDC]j%KXK 'P@$I=Y%C%gx'$!V(ekڤք'Qt!x7xbJ7 o߼W_y|nʒ;Fido/_1z/L?>o_;9:33`=—S,FĔ觑@)R8elmEv|!ո/,Ә%qh|'1:`ij.̳u'k CZ^WcK0'E8S߱sˮdΙ`K}A"NșM1I/AeހQתGF@A~eh-QR9C 5 ~d"9 0exp<^!͸~J7䒜t L䈝c\)Ic8E&]Sf~@Aw?'r3Ȱ&2@7k}̬naWJ}N1XGVh`L%Z`=`VKb*X=z%"sI<&n| .qc:?7/N<Z*`]u-]e|aѸ¾|mH{m3CԚ .ÕnAr)[;-ݑ$$`:Ʊ>NVl%kv:Ns _OuCX=mO4m's߸d|0n;pt2e}:zOrgI( 'B='8\L`"Ǚ 4F+8JI$rՑVLvVxNN";fVYx-,JfV<+k>hP!aLfh:HHX WQXt,:JU{,Z BpB)sֻڙӇiE4(=U\.O. +x"aMB[F7x"ytѫиK-zz>F>75eo5C9Z%c7ܼ%6M2ˊ 9B" N "1(IzZ~>Yr]H+9pd\4n(Kg\V$=]B,lוDA=eX)Ly5ot e㈮bW3gp : j$/g*QjZTa!e9#i5*j5ö fE`514g{7vnO(^ ,j~V9;kvv"adV݊oTAn7jah+y^@ARhW.GMuO "/e5[s󿬅`Z'WfPt~f}kA'0z|>ܙ|Uw{@՘tAm'`4T֠2j ۣhvWwA9 ZNU+Awvhv36V`^PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!g theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] [ z gggggjf  "5#q##8$%T'['356789:< n>2F_t*=Ti&[' !"#$%&'()*+,-./0124;8[XIPRWbdj!8@0(  B S  ?^i de+5Zbdn168Y\}  $ :Ede\cY\3333333333h^ddDM ,f=BB C B /2WZ-5;EIW\J{"8 ȜUB  ,-i\-n@IV0~L"H2#p56h49½t]/:"1:z5c@9&7 @ȏa3F.bKP M>OCVo'R8a]RLB^R${KO^7XiUdJ@KFjB$vpod\s~S*u*hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h^`CJOJQJo(mh ^`OJ QJ o(oh p^p`OJ QJ o(h @ ^@ `OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJ QJ o(oh P^P`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o( ^`OJQJo(q ^`OJQJo(q pp^p`OJQJo(q @ @ ^@ `OJQJo(q ^`OJQJo(q ^`OJQJo(q ^`OJQJo(q ^`OJQJo(q PP^P`OJQJo(qh^`CJOJQJo(mh ^`OJ QJ o(oh p^p`OJ QJ o(h @ ^@ `OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJ QJ o(oh P^P`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h^`CJOJQJo(mh ^`OJ QJ o(oh p^p`OJ QJ o(h @ ^@ `OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJ QJ o(oh P^P`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h^`CJOJQJo(mh ^`OJ QJ o(oh p^p`OJ QJ o(h @ ^@ `OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJ QJ o(oh P^P`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h^`CJOJQJo(mh ^`OJ QJ o(oh p^p`OJ QJ o(h @ ^@ `OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJ QJ o(oh P^P`OJ QJ o(h^`CJOJQJo(mh ^`OJ QJ o(oh p^p`OJ QJ o(h @ ^@ `OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJ QJ o(oh P^P`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o(hh^h`^J.h8^8`^J.hL^`L^J.h ^ `^J.h ^ `^J.hxL^x`L^J.hH^H`^J.h^`^J.hL^`L^J.hh^h`CJOJQJo(qh 8^8`OJ QJ o(oh ^`OJ QJ o(h  ^ `OJQJo(h  ^ `OJ QJ o(oh x^x`OJ QJ o(h H^H`OJQJo(h ^`OJ QJ o(oh ^`OJ QJ o( d\sa3F*u\-o'R{LB^@KFjiUdc@ @"1:bK{KO^/:M>OIV0,- 49p5$vpB a]R"H2x& @CJ@OJQJo(& @CJ0OJQJo(& @CJ$OJQJo(m蹈& @CJ8OJQJo(X& @CJ0OJQJo(q& @CJ$OJQJo(q@& @CJ*OJQJo(m`        `        @f        `        `        `        t/> ق/:c.|R.Z`Z,=8r&.@f        `        @f        `        `        `        `        `        @f        `        @f        @f        `        `        `        `                 `        jtD#StD#% o CV# t5tD#T&K$#>1t]p#t]pQ@!&K$#dy$=N#&K$!*V#]m-tD#n0t]p#Fu>% #tD;F -G =NM?Q% #VKrX=N#yj)\tD#9I*i&K$##Ojt]p#< al% #yqvtD#P[Owt]p#%iG&&)*71uC%PDQGlLg)NENySz#{% 7X,eV"ZCcSg{@[h@Unknown G*Ax Times New Roman5Symbol3. *Cx Arial5"System7.@Calibri7@Cambria5. .[`)TahomaC.,{ @Calibri LighteMonotype SortsSegoe UI Symbol?= *Cx Courier New;WingdingsA$BCambria Math"Ah\FWiT8T8!xx23q$PcS2! xxiRV mplonsky Plonsky, Markt                     Oh+'0x  4 @ LX`hp mplonsky Normal.dotmPlonsky, Mark16Microsoft Office Word@@@d*T՜.+,D՜.+,, hp|  8  Title 8@ _PID_HLINKSAVIhttp://news.health.com/2015/06/05/fda-panel-endorses-womens-libido-pill/  !"#$%&'()*+,-./0123456789:;<=?@ABCDEGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|~Root Entry F Data >1TableFmWordDocument7zSummaryInformation(}DocumentSummaryInformation8CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q